Plavix and Granix drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Plavix (clopidogrel bisulfate) and Granix (tbo-filgrastim). Common drug interactions include platelet count decreased among females and fatigue among males.
The phase IV clinical study analyzes what interactions people have when they take Plavix and Granix. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.
What is Plavix?
Plavix has active ingredients of clopidogrel bisulfate. It is often used in stent. eHealthMe is studying from 151,179 Plavix users. Check the latest studies of Plavix.
What is Granix?
Granix has active ingredients of tbo-filgrastim. eHealthMe is studying from 897 Granix users. Check the latest studies of Granix.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
14 people who take Plavix and Granix together, and have interactions are studied.

What are the common drug interactions of Plavix and Granix, by gender? *:
female:
- Platelet count decreased
- Anaemia (lack of blood)
- Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
- Alanine aminotransferase increased
- Aspartate aminotransferase increased
- Blood albumin decreased
- Blood creatinine increased
- Blood glucose decreased
- Drug ineffective
- Haematocrit
male:
- Fatigue (feeling of tiredness)
- Asthenia (weakness)
- Nasopharyngitis (inflammation of the nasopharynx)
- Plasma cell myeloma (cancer that begins in plasma cells)
- Pneumonia
- Protein total increased
- Pulmonary thrombosis (scarring in the lungs)
- White blood cell count decreased
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Pneumonitis (inflammation of the walls of the alveoli in the lungs)
What are the common drug interactions of Plavix and Granix, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Alanine aminotransferase increased
- Aspartate aminotransferase increased
- Blood albumin decreased
- Blood glucose decreased
- Haematocrit
- Platelet count decreased
- Pulmonary embolism (blockage of the main artery of the lung)
- Pyrexia (fever)
- Red blood cell count decreased
- Red cell distribution width increased
50-59:
- Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
60+:
- Anaemia (lack of blood)
- Fatigue (feeling of tiredness)
- Fluid retention (an abnormal accumulation of fluid in the blood)
- Insomnia (sleeplessness)
- Pneumonia
- White blood cell count decreased
- Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
- Platelet count decreased
- Asthenia (weakness)
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
What are the existing conditions these people have? *
- Multiple Myeloma (cancer of the plasma cells): 6 people, 42.86%
- Osteoporosis (bones weak and more likely to break): 3 people, 21.43%
- Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 3 people, 21.43%
- Lung Disorder (lung disease): 3 people, 21.43%
- Hypersensitivity: 3 people, 21.43%
- Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 21.43%
- Constipation: 3 people, 21.43%
- Neoplasm Malignant (cancer tumour): 2 people, 14.29%
- Lymphoma (cancer that begins in immune system cells): 2 people, 14.29%
- White Blood Cell Count Decreased: 1 person, 7.14%
* Approximation only. Some reports may have incomplete information.
Do you take Plavix and Granix?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Plavix and Granix:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Plavix:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Granix:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Plavix and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Granix and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on clopidogrel bisulfate and tbo-filgrastim (the active ingredients of Plavix and Granix, respectively), and Plavix and Granix (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Rythmol Sr and Atrial Fibrillation for Men aged 60+ - now
- Rythmol Sr and Auricular Fibrillation for Men aged 60+ - now
- Rythmol Sr and A-Fib for Men aged 60+ - a second ago
- Could Prograf cause Lymphoproliferative Disorder? - 6 seconds ago
- Could Amphotericin B cause Agranulocytosis? - 16 seconds ago
- Could Prednisone cause Drug Clearance Decreased? - 26 seconds ago
- Drug interactions of Abilify and Rabeprazole - 34 seconds ago
- Could Benicar Hct cause Hyperkalemia? - 34 seconds ago
- Senna and Calcium Gluconate drug interactions for women aged 50-59 - 41 seconds ago
- Could Claritin cause Diverticulitis? - 42 seconds ago